首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1812429

血液培養檢測市場：依方法、產品、技術、應用、最終用戶和地區分類

Blood Culture Test Market, By Method, By Product, By Technology, By Application, By End User, By Geography

出版日期: 2025年08月28日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

血液培養檢測市場規模預計在 2025 年達到 65.4 億美元，預計到 2032 年將達到 138.4 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 11.3%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	65.4億美元
效能數據	2020年至2024年	預測期	2020年至2024年
預測期：2025-2032年複合年成長率：	11.30%	2032年的價值預測	138.4億美元

全球血液培養檢測市場是診斷醫療保健產業的關鍵部分，也是檢測和識別血液感染疾病、敗血症和菌血症的關鍵。

血液培養檢測是指從患者體內抽取血液樣本，並在專門的培養基中進行培養，以檢測血液中可能存在的致病微生物，例如細菌、真菌和酵母菌。隨著技術的進步，這項診斷技術已顯著發展，從傳統的手動方法發展到自動化系統，從而提高了準確性、縮短了結果獲取時間並改善了臨床療效。

該市場包括各種測試技術，如常規培養、自動化血液培養系統、分子診斷技術等。世界各地的醫療機構高度依賴血液培養測試，因為它為選擇適當的抗生素治療和患者管理策略提供了重要資訊。

醫院內感染的增加、人們對敗血症早期診斷認知的提高以及對抗生素管理計劃的日益重視，使得血液培養檢測成為現代醫療保健的重要工具。市場涉及診斷實驗室、醫院、血庫和研究機構等各類相關人員，所有這些都推動了對可靠且高效的血液培養檢測解決方案的需求不斷成長。

市場動態

全球血液培養檢測市場的成長受到多種重要因素的驅動，這些因素共同推動了其成長軌跡。主要促進因素是全球血液感染疾病和敗血症發病率的上升，這推動了對快速且準確的診斷解決方案的需求。醫院內感染的日益流行，加上癌症治療、器官移植和慢性疾病導致的免疫力缺乏患者的增加，正在創造巨大的市場需求。自動化血液培養系統的技術進步，使其檢測時間更快、靈敏度更高，是關鍵的成長催化劑。

此外，日益成長的老年人口（老年人易感染疾病）以及外科手術數量的增加也促進了市場的成長。然而，市場中也存在一些限制因素，例如自動化血液培養系統及其維護的高成本，這可能會限制其在資源受限的醫療環境中的應用。血液培養程序的複雜性（需要熟練的實驗室人員）以及污染導致假陽性結果的風險也帶來了額外的挑戰。診斷設備的嚴格監管要求以及傳統培養方法的耗時性也可能阻礙市場的成長。

然而，快速分子診斷技術和就地檢驗解決方案的開發蘊藏著巨大的機遇，這些技術能夠在數小時內（而非數天內）得出結果。新興市場醫療基礎設施的不斷擴張、醫療成本的不斷上漲以及對個人化醫療日益成長的關注，都為市場拓展提供了巨大的機會。將人工智慧和機器學習融入血液培養系統以增強解讀能力，以及開發能夠同時檢測多種病原體的多重檢測平台，都為市場拓展提供了廣闊的前景。

本次調查的主要特點

本報告對全球血液培養檢測市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球血液培養檢測市場的主要企業。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球血液培養檢測市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球血液培養檢測市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 6.54 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.30%	2032 Value Projection:	USD 13.84 Bn

Blood culture testing involves the collection of blood samples from patients and their cultivation in specialized media to detect the presence of pathogenic microorganisms, including bacteria, fungi, and yeasts that may be circulating in the bloodstream. This diagnostic methodology has evolved significantly with technological advancements, transitioning from traditional manual methods to automated systems that offer enhanced accuracy, reduced time-to-results, and improved clinical outcomes.

The market encompasses various testing methodologies, including conventional culture methods, automated blood culture systems, and molecular diagnostic techniques. Healthcare facilities worldwide rely heavily on blood culture testing as it provides crucial information for appropriate antibiotic therapy selection and patient management strategies.

The increasing prevalence of hospital-acquired infections, rising awareness about early diagnosis of sepsis, and growing emphasis on antimicrobial stewardship programs have positioned blood culture testing as an indispensable tool in modern healthcare. The market includes various stakeholders such as diagnostic laboratories, hospitals, blood banks, and research institutions, all contributing to the expanding demand for reliable and efficient blood culture testing solutions.

Market Dynamics

The global blood culture test market growth is driven by several compelling factors that collectively propel its growth trajectory. The primary driver is the escalating incidence of bloodstream infections and sepsis globally, which has intensified the demand for rapid and accurate diagnostic solutions. The increasing prevalence of hospital-acquired infections, coupled with the growing number of immunocompromised patients due to cancer treatments, organ transplants, and chronic diseases, has created a substantial market demand. Technological advancements in automated blood culture systems, offering faster detection times and improved sensitivity, serve as significant growth catalysts.

Additionally, the growing geriatric population, which is more susceptible to infections, and the increasing number of surgical procedures contribute to market growth. However, the market faces certain restraints including the high cost of automated blood culture systems and their maintenance, which can limit adoption in resource-constrained healthcare settings. The complexity of blood culture procedures requiring skilled laboratory personnel and the risk of contamination leading to false-positive results pose additional challenges. Stringent regulatory requirements for diagnostic devices and the time-consuming nature of traditional culture methods can also impede market growth.

Nevertheless, significant opportunities exist in the development of rapid molecular diagnostic techniques and point-of-care testing solutions that can deliver results within hours rather than days. The expansion of healthcare infrastructure in emerging markets, increasing healthcare expenditure, and the growing focus on personalized medicine present lucrative opportunities. The integration of artificial intelligence and machine learning in blood culture systems for enhanced interpretation and the development of multiplex testing platforms for simultaneous detection of multiple pathogens represent promising avenues for market expansion.

Key Features of the Study

This report provides in-depth analysis of the global blood culture test market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood culture test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Becton, Dickinson and Company (BD), bioMerieux S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Roche Diagnostics, Siemens Healthineers AG, Abbott Laboratories, Bruker Corporation, T2 Biosystems Inc., Cepheid Inc., Luminex Corporation, Merck KGaA (MilliporeSigma), Sartorius AG, QIAGEN N.V., and BioFire Diagnostics LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood culture test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood culture test market

Market Segmentation

Method Insights (Revenue, USD Bn, 2020 - 2032)
- Automated Blood Culture
- Conventional/Manual Blood Culture
Product Insights (Revenue, USD Bn, 2020 - 2032)
- Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
- Instruments (Automated blood culture systems, laboratory equipment)
- Software and Services
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Culture-Based Technologies (including conventional, resin-based)
- Molecular Technologies (NAAT, PCR-based panels, Microarrays)
- Proteomic Technologies (MALDI-TOF, LC-MS)
Application Insights (Revenue, USD Bn, 2020 - 2032)
- Bacterial Infections (e.g., bacteremia, septicemia)
- Fungal Infections (e.g., fungemia)
- Mycobacterial Infections
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Laboratories
- Diagnostic Laboratories
- Academic and Research Institutes
- Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Becton, Dickinson and Company (BD)
- bioMerieux S.A.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Roche Diagnostics
- Siemens Healthineers AG
- Abbott Laboratories
- Bruker Corporation
- T2 Biosystems Inc.
- Cepheid Inc.
- Luminex Corporation
- Merck KGaA (MilliporeSigma)
- Sartorius AG
- QIAGEN N.V.
- BioFire Diagnostics LLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blood Culture Test Market, By Method
- Global Blood Culture Test Market, By Product
- Global Blood Culture Test Market, By Technology
- Global Blood Culture Test Market, By Application
- Global Blood Culture Test Market, By End User
- Global Blood Culture Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Blood Culture Test Market, By Method, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Automated Blood Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Conventional/Manual Blood Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Blood Culture Test Market, By Product, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Instruments (Automated blood culture systems, laboratory equipment)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Blood Culture Test Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Culture-Based Technologies (including conventional, resin-based)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Molecular Technologies (NAAT, PCR-based panels, Microarrays)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Proteomic Technologies (MALDI-TOF, LC-MS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Blood Culture Test Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Bacterial Infections (e.g., bacteremia, septicemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Fungal Infections (e.g., fungemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mycobacterial Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Blood Culture Test Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Blood Culture Test Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
T2 Biosystems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cepheid Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Luminex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioFire Diagnostics LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies